Evidence map›Paper›PMID 34641494›Full record

ReviewMolecules (Basel, Switzerland)2021

Cellular and Molecular Engineering of Glycan Sialylation in Heterologous Systems.

Ryoma Hombu, Sriram Neelamegham, Sheldon Park

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ryoma HombuDepartment of Chemical and Biological Engineering, University at Buffalo, Buffalo, NY 14260, USA.
Sriram NeelameghamDepartment of Chemical and Biological Engineering, University at Buffalo, Buffalo, NY 14260, USA.
Sheldon ParkDepartment of Chemical and Biological Engineering, University at Buffalo, Buffalo, NY 14260, USA.ORCID 0000-0002-3831-000X
University at Buffalo, State University of New York · US

Funding

Systems Biology of GlycosylationR01HL103411 · NHLBI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI NEELAMEGHAM, SRIRAM · 2011 to 2025
$7.1M
Engineering of glycosyltransferases to obtain glycan binding proteinsR21GM139160 · NIGMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI NEELAMEGHAM, SRIRAM, PARK, SHELDON · 2020 to 2021
$422k
NHLBI NIH HHS R01 HL103411NIGMS NIH HHS R21 GM139160NIH HHS GM139160 HL103411
6 · The paper itself

Abstract

Glycans have been shown to play a key role in many biological processes, such as signal transduction, immunogenicity, and disease progression. Among the various glycosylation modifications found on cell surfaces and in biomolecules, sialylation is especially important, because sialic acids are typically found at the terminus of glycans and have unique negatively charged moieties associated with cellular and molecular interactions. Sialic acids are also crucial for glycosylated biopharmaceutics, where they promote stability and activity. In this regard, heterogenous sialylation may produce variability in efficacy and limit therapeutic applications. Homogenous sialylation may be achieved through cellular and molecular engineering, both of which have gained traction in recent years. In this paper, we describe the engineering of intracellular glycosylation pathways through targeted disruption and the introduction of carbohydrate active enzyme genes. The focus of this review is on sialic acid-related genes and efforts to achieve homogenous, humanlike sialylation in model hosts. We also discuss the molecular engineering of sialyltransferases and their application in chemoenzymatic sialylation and sialic acid visualization on cell surfaces. The integration of these complementary engineering strategies will be useful for glycoscience to explore the biological significance of sialic acids on cell surfaces as well as the future development of advanced biopharmaceuticals.

Indexed as

AnimalsGlycosylationHumansPolysaccharidesSialic AcidsSialyltransferasesPolysaccharidesSialic AcidsSialyltransferasescarbohydrate-active enzymecell free protein synthesischemoenzymatic synthesisglycoproteinspathway engineeringprotein engineeringsialic acidstherapeutic proteins

Identifiers

PMID34641494
PMCPMC8512710
OpenAlexW3203756806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.